We are lowering the cost of life-saving drugs and putting people ahead of shareholder profits. 

About us

Our Vision

NP2 is a leader in nonprofit pharma. We believe that everyone—regardless of income or life circumstances— should have access to the life-saving medicines they need. NP2’s innovative model will reduce rapidly escalating generic drug prices for some of the most widely used oncology drugs and those used to treat infectious diseases and more.

Our Expertise

With more than 100 years of combined experience in the fields of medicine, clinical drug trials, and the pharmaceutical industry, our expert leadership team will advance public health and define a new model in pharmaceutical care.

 average cost of one year of cancer treatment in the U.S. in 2019


of cancer patients in the U.S. experience financial hardship in affording their treatment


of U.S. cancer patients do not complete their treatment due to the high cost of care

Americans have experienced medication insecurity in the last 12 months

Get involved

Join Us

NP2 needs your help to ensure that all Americans have access to the life-saving medicines they need. Be a changemaker and help us create a new paradigm—one that puts public health ahead of profits. Your tax-deductible donation will help us lower the cost of generic drugs for the under-served and for all Americans, today, tomorrow, and for years to come.


“NP2 is tackling one of the most significant health crises facing millions of Americans—the sky-rocketing cost of generic life-saving drugs. I am proud to support NP2 in creating a new model that will put people ahead of profits. The time is now to change the old paradigm and NP2 is just the organization to do it. “

Judith A.

“As a Pain Management Specialist, I am privy to the exorbitant prices my patients often face filling a prescription for the medicines they need. I too have experienced this first-hand when I was told my co-pay would be more than $1,000 for ear drops. I am unable to understand these prices except beyond excess in corporate profits. NP2’s nonprofit pharma model eliminates this and will benefit individuals and healthcare institutions alike.”

Michael Parr, MD, Addiction Medicine Specialist

“NP2 is an incredibly important venture…It is good for patients, good for hospitals and good for research.”

Steve Libutti, MD, Director, Rutgers Cancer Institute

“NP2 exemplifies what’s right about the biopharma industry. Using their powerful, combined expertise, these pharma veterans are creating fairly priced, life-saving or sustaining generic medications for patients who really need them. I am highly enthusiastic to support their remarkably uncommon efforts.”

David Hardy, MD, Adjunct Clinical Professor of Medicine, University of Southern California

“As a patient, I know of the devastating financial consequences of having a complex illness that required extensive and expensive treatment over a long period of time. Despite having health insurance I still had to borrow money from family and go into debt to cover the cost of my care. No one in America should be faced with this kind of stress when their energy should be focused on getting well. I am grateful for NP2 and their bold new model to bring down the cost of pharmaceutical care.”

C.J. Simon, NP2 supporter

“When it comes to cancer patients and their families, the last thing they should worry about is getting access to affordable treatments. The promise of NP2 is ensuring that cancer clinics around the U.S. are reliably equipped with essential chemotherapies at affordable costs. NP2 has an important role to play in alleviating the burden of financial toxicity and unpredictable supply on cancer patients and clinics.”

Kahaari Kenyatta, Drug Pricing Policy Analyst

Interested in finding out more about our Legacy Circle?